Catalyst Wire Dossier Catalyst Wire Dossier

Bupivacaine-meloxicam dual-agent local analgesic

bupivacaine and meloxicam · TriHealth Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bupivacaine-meloxicam dual-agent local analgesic, covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery [Phase 3]

See pricing